E-LIB Suche - Ergebnisse für: Aslanis, Vassilios

1

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOL..:

Harrison, Claire ; Mascarenhas, John ; Cilloni, Daniela...
HemaSphere. 7 (2023) S3 - p. e87048d4 , 2023

2

Safety and pharmacokinetics of GB1211, an oral galectin-3 i..:

Aslanis, Vassilios ; Slack, Robert J. ; MacKinnon, Alison C....
Cancer Chemotherapy and Pharmacology. 91 (2023) 3 - p. 267-280 , 2023

Link: https://doi.org/10.1007/..

3

Multiple administrations of fluconazole increase plasma exp..:

Aslanis, Vassilios ; Umehara, Kenichi ; Huth, Felix...
Cancer Chemotherapy and Pharmacology. 84 (2019) 4 - p. 749-757 , 2019

Link: https://doi.org/10.1007/..

4

Modeling and Simulation Support Eltrombopag Dosing in Pedia..:

Wire, Mary B. ; Li, Xiaobin ; Zhang, Jianping...
Clinical Pharmacology & Therapeutics. 104 (2018) 6 - p. 1199-1207 , 2018

Link: https://doi.org/10.1002/..

5

Effect of cyclosporine coadministration on the pharmacokine..:

Aslanis, Vassilios ; Zhang, Jianping ; Lomeli, Barbara..
Cancer Chemotherapy and Pharmacology. 82 (2018) 5 - p. 847-855 , 2018

Link: https://doi.org/10.1007/..

6

Pharmacokinetics, safety, and tolerability of siponimod (BA..:

Shakeri-Nejad, Kasra ; Aslanis, Vassilios ; Veldandi, Uday...
Int. Journal of Clinical Pharmacology and Therapeutics. 55 (2017) 1 - p. 41-53 , 2017

Link: https://doi.org/10.5414/..

7

Cardiac Effects of Siponimod (BAF312) Re-initiation After V..:

Legangneux, Eric ; Shakeri-Nejad, Kasra ; Aslanis, Vassilios...
Clinical Therapeutics. 38 (2016) 3 - p. 631-645.e1 , 2016

Link: https://doi.org/10.1016/..

8

Effects of Therapeutic and Supratherapeutic Doses of Siponi..:

Shakeri-Nejad, Kasra ; Aslanis, Vassilios ; Veldandi, Uday Kiran...
Clinical Therapeutics. 37 (2015) 11 - p. 2489-2505.e2 , 2015

Link: https://doi.org/10.1016/..

9

Pharmacokinetics, Safety and Tolerability of Siponimod (BAF..:

Shakeri-Nejad, Kasra ; Aslanis, Vassilios ; Veldandi, Uday Kiran...
Neurology. 84 (2015) 14_supplement - p. , 2015

Link: https://doi.org/10.1212/..

10

Effects of Therapeutic and Supratherapeutic Doses of Siponi..:

Shakeri-Nejad, Kasra ; Mooney, Louise ; Aslanis, Vassilios...
Neurology. 82 (2014) 10_supplement - p. , 2014

Link: https://doi.org/10.1212/..

11

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOL..:

Harrison, Claire ; Mascarenhas, John ; Cilloni, Daniela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431423/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Safety and pharmacokinetics of GB1211, an oral galectin-3 i..:

Aslanis, Vassilios ; Slack, Robert J ; MacKinnon, Alison C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010643/. , 2023

Link: http://www.ncbi.nlm.nih...

13

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A ..:

Gaughan, Erin E ; Quinn, Tom M ; Mills, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893334/. , 2022

Link: http://www.ncbi.nlm.nih...

14

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOL..:

Claire Harrison ; John Mascarenhas ; Daniela Cilloni...
http://journals.lww.com/10.1097/01.HS9.0000970996.87048.d4. , 2023

Link: https://doi.org/10.1097/..